Lidonostrum

Lidocaine, the active ingredient in Lidonostrum, is a local anesthetic presented as a topical preparation for cutaneous use. It provides temporary loss of sensation for skin anesthesia, pain relief, and relief of itching. GNH USA supplies Lidonostrum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidonostrum is a local anesthetic that acts on peripheral nerve sodium channels to provide surface analgesia. - Local anesthesia of skin: produces temporary numbness for minor surgical or diagnostic procedures. - Pain relief: reduces superficial pain associated with minor injuries or procedures. - Pruritus: alleviates itching by blocking sensory nerve transmission.

Adverse reactions may occur following cutaneous application of lidocaine.

Common Side Effects: - Mild skin irritation or burning sensation at the application site. - Redness or erythema. - Localized itching. - Swelling or edema. - Transient numbness extending beyond the intended area. - Dryness or peeling of the skin.

Serious or Rare Side Effects: - Allergic reactions such as urticaria, angioedema, or anaphylaxis. - Systemic toxicity manifesting as dizziness, tinnitus, or seizures. - Cardiac arrhythmias or conduction disturbances. - Methemoglobinemia. - Severe skin necrosis or ulceration. - Persistent numbness or motor weakness.

When using Lidonostrum, consider the following safety measures. - Allergy assessment: verify that the patient has no known hypersensitivity to lidocaine or amide‑type anesthetics. - Application area: avoid applying to broken skin, mucous membranes, or extensive open wounds. - Dose limitation: adhere strictly to the prescribed amount to prevent systemic absorption. - Concurrent anesthetics: do not combine with other topical anesthetics without medical guidance. - Pregnancy and lactation: consult a prescriber as safety data are limited. - Store below 25°C: keep in the original container, protect from moisture and light.

Lidonostrum may interact with other medicines that affect cardiac or nervous system function.

Major Interactions (Avoid): - Other amide‑type local anesthetics: concurrent use can increase systemic toxicity. - Class I antiarrhythmics (e.g., quinidine, procainamide): may enhance cardiotoxic effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may reduce lidocaine metabolism.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask early signs of lidocaine toxicity. - Diuretics: can alter plasma concentrations of lidocaine. - General anesthetics: may potentiate central nervous system depression.